RAYMOND JAMES & ASSOCIATES - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 254 filers reported holding CONMED CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$8,366,353
-23.8%
82,959
+2.6%
0.01%
-22.2%
Q2 2023$10,983,641
+2.7%
80,828
-21.5%
0.01%0.0%
Q1 2023$10,696,790
+30.1%
102,993
+11.1%
0.01%
+12.5%
Q4 2022$8,219,901
+6.7%
92,734
-3.5%
0.01%0.0%
Q3 2022$7,706,000
-22.8%
96,117
-7.8%
0.01%
-20.0%
Q2 2022$9,983,000
-36.1%
104,253
-0.9%
0.01%
-23.1%
Q1 2022$15,625,000
+7.1%
105,183
+2.2%
0.01%
+8.3%
Q4 2021$14,583,000
+7.6%
102,874
-0.7%
0.01%0.0%
Q3 2021$13,550,000
+7.1%
103,569
+12.5%
0.01%0.0%
Q2 2021$12,649,000
+5.3%
92,037
+0.0%
0.01%0.0%
Q1 2021$12,017,000
+22.7%
92,021
+5.3%
0.01%
+9.1%
Q4 2020$9,790,000
+46.2%
87,409
+2.7%
0.01%
+37.5%
Q3 2020$6,695,000
+6.5%
85,102
-2.5%
0.01%0.0%
Q2 2020$6,284,000
+45.8%
87,284
+16.0%
0.01%
+14.3%
Q1 2020$4,310,000
-18.1%
75,252
+59.9%
0.01%0.0%
Q4 2019$5,264,000
+18.5%
47,075
+1.9%
0.01%
+16.7%
Q3 2019$4,441,000
+25.7%
46,190
+11.9%
0.01%
+20.0%
Q2 2019$3,532,000
+50.7%
41,276
+46.5%
0.01%
+25.0%
Q1 2019$2,343,00028,1690.00%
Other shareholders
CONMED CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Iron Triangle Partners LP 190,000$24,858,0003.57%
Ranger Investment Management 253,789$33,203,0001.77%
EARNEST PARTNERS LLC 1,603,130$209,737,0001.28%
Penn Capital Management Company, LLC 92,086$12,048,0001.22%
Champlain Investment Partners, LLC 1,492,419$195,253,0000.94%
MOODY ALDRICH PARTNERS LLC 53,257$6,968,0000.88%
Hood River Capital Management LLC 215,384$28,179,0000.87%
OAK RIDGE INVESTMENTS LLC 71,880$9,404,0000.83%
WAFRA INC. 138,542$18,125,0000.66%
EPIQ PARTNERS, LLC 10,463$1,369,0000.63%
View complete list of CONMED CORP shareholders